YUMAB’s antibody discovery and development ... but great effort is being channeled into targeting more complex and difficult antigens, such as multimembrane-spanning receptors, receptor ...
Here, we discuss strategies to select the best therapeutic antigen targets, to optimize the structure of IgG antibodies and to design related or new structures with additional functions.
Stephanie Stephens Determining how to predict the antibody-antigen interactions was the biggest challenge. The researchers focused on the COVID-19 virus because it had many complex antigen-binding ...
Determining how to predict the antibody-antigen interactions was the biggest challenge. The researchers focused on the Covid-19 virus because it had many complex antigen-binding sequences and epitopes ...
(Nasdaq: VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treating cancer and neurodegenerative disease through the inhibition of SEMA4D, today announced the ...